Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2014-12-31 to 2015-01-26
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Well documented study performed according to OECD guideline 476, in compliance with GLP. No deviations were noted.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 015
- Report date:
- 2015
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- mammalian cell gene mutation assay
Test material
- Details on test material:
- - Name of test material (as cited in study report): XTA 823- Substance type: clear yellow liquid- Physical state: liquid- Analytical purity: 50% (provided by the sponsor) - Purity test date: no data- Lot/batch No.: BLW0010057- Expiration date of the lot/batch: no data- Stability under test conditions: not determined. The study conclusion was based on the test substance as supplied.- Storage condition of test material: 2 to 8°C, protected from light- other: -molecular weight: 350-390 g/mol
Constituent 1
Method
- Target gene:
- thymidine kinase locus
Species / strain
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- - Type and identity of media: L5178Y/TK+/- mouse lymphoma cells, clone 3.7.2C, received from Patricia Poorman-Allen, Glaxo Wellcome Inc., Research Triangle Park, NC- Properly maintained: yes- Periodically checked for Mycoplasma contamination: yes, each batch of frozen cells was tested using agar culture and Hoechst staining procedures and found to be free of mycoplasma contamination- Periodically checked for karyotype stability: no data- Periodically "cleansed" against high spontaneous background: yes, prior to use in th assay, L518Y/TK+/- cells were cleansed to reduce the frequency of spontaneously occurring TK+/- cells.
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254-induced rat liver S9 from Sprague-Dawley rat
- Test concentrations with justification for top dose:
- preliminary toxicity test: 15.2, 30.5, 60.9, 122, 244, 489, 975, 1950, 3900 µg/mlmouse lymphoma assay: - 4-hour treatment, with and without metabolic activation: 244, 488, 975, 1950, 2930, 3900 µg/ml- 24-hour treatment, without metabolic activation: 7.62, 15.2, 30.5, 60.9, 91.4, 122, 183, 224 µg/ml
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: water- Supplier: Gibco- Lot number: 1420169- CAS number: 7732-18-5- Purity/grade: sterile, distilled- Expiration date: 2015-08-30- Justification for choice of solvent/vehicle: water was selected as the vehicle of choice based on the solubility of the test substance and compatibility with the target cells. The test substance formed a clear solution in sterile, distilled water at a concentration of ~50 mg/ml (the maximum evaluated).
Controlsopen allclose all
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- methylmethanesulfonate
- Remarks:
- 15 and 20 µg/ml for the 4-hour treatment and 5.0 and 7.5 µg/ml for the 24-hour treatment (diluted in same vehicle as test substance), without metabolic activation
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 7,12-dimethylbenzanthracene
- Remarks:
- 1.0 and 1.5 µg/ml (in DMSO as vehicle), with metabolic activation
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in mediumPRELIMINARY TOXICITY TEST FOR SELECTION OF DOSE LEVELS:- L5178Y/TK+/- cells were exposed to the vehicle in duplicate cultures and nine concentrations of test substance using single cultures. The test substance was evaluated at the maximum concentration of 10 mM. The pH of cultures at a concentration of 3900 µg/ml was adjusted within 6.5 to 7.5 using 1N sodium hydroxide (NaOH, CAS no. 1310-73-2); lot no. RNBD0654, expiration 2017-06-30, supplier: Sigma-Aldrich). No pH adjustment was made for the remaining concentrations. The osmolality of the vehicle control and the highest treatment condition also was measured at the beginning of treatment. Dose levels for the definitive assay were based upon post-treatment cytotoxicity (growth inhibition relative to the vehicle control). DURATION- Exposure duration: 4 hours in the presence and absence of S9, 24 hours in the absence of S9- Expression time (cells in growth medium): 10-14 days- Fixation time (start of exposure up to fixation or harvest of cells): at the end of the exposure period, the cells were washed with culture medium and collected by centrifugation. The cells were resuspended in 20 ml F10P on day 1 and in 10 ml F10P on day 2, and incubated at 37 ± 1°C for two days following treatment. Cell population adjustments to 3 x 10E05 cells/ml were made as follows: 4 hour treatment: 1 and 2 days after treatment; 24 hour treatment: immediately after test substance removal, and 2 and 3 days after treatment. pH: the pH of cultures at a concentration of 3900 µg/mL again were adjusted to within 6.5 to 7.5 using the same 1N NaOH as above. No pH adjustment was made for the remaining concentrations. SELECTION AGENT (mutation assays): 2-4 µg TFT/mL at a density of 1 x 1E06 cells/100mm plate in cloning medium containing 0.22 to 0.24% agarNUMBER OF REPLICATIONS: duplicate cultures for all dose levels and vehicle, single culture for positive controlNUMBER OF CELLS EVALUATED: 3 x 1E06DETERMINATION OF CYTOTOXICITY- Method: relative total growthOTHER EXAMINATIONS:- Induced mutant frequency (IMF)- The precipitation was determined with the unaided eye at the beginning and conclusion of treatment
- Evaluation criteria:
- In evaluation of the data, increases in induced mutant frequency which occured only at highly toxic concentrations (i.e., less than 10% total growth) were not considered biologically relevant. All conclusions were based on scientific judgment; however, the following criteria are presented as a guide to interpretation of the data:- A result was considered positive if a concentration-related increase in mutant frequency was observed in the treated cultures and one or more treatment conditions with 10% or greater total growth exhibit induced mutant frequencies of ≥90 mutants per 10E06 clonable cells (based on the average mutant frequency of duplicate cultures). If the average vehicle control mutant frequency was >90 mutants per 10E06 clonable cells, a doubling of mutant frequency over the vehicle would also be required (Mitchell et al., 1997). - A result was considered negative if the treated cultures exhibit induced mutant frequencies of less than 90 mutants per 10E06 clonable cells (based on the average mutant frequency of duplicate cultures) and there was no concentration-related increase in mutant frequency. There are some situations in which a chemical would be considered negative when there was no culture showing between 10 to 20% survival:- There was no evidence of mutagenicity (e.g. no dose response or increase in induced mutant frequencies between 45 and 89 mutants per 10E06) in a series of data points within 100 to 20% survival and there was at least one negative data point between 20% and 25% survival. - There was no evidence of mutagenicity (e.g. no dose response or increase in induced mutant frequencies between 45 and 89 mutants per 10E6) in a series of data points between 100 to 25% survival and there was also a negative data point between 10% and 1% survival. In this case, it would be acceptable to count the TFT colonies of cultures exhibiting <10% total growth.
- Statistics:
- no data
Results and discussion
Test results
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS- Effects of pH: pH adjustment was required at a concentration of 3900 μg/ml to maintain neutral pH- Effects of osmolality: test substance did not have an adverse impact on the osmolality of the cultures [251 and 258 mmol/kg for the vehicle control and the highest treatment concentration (3900 µg/mL), respectively]. (preliminary toxicity test)- Evaporation from medium: no data- Water solubility: no data- Precipitation: no visible precipitate was observed at the beginning or end of treatment. PRELIMINARY TOXICITY ASSAY: - No visible precipitate was observed at the beginning or end of treatment, and the test substance did not have an adverse impact on the osmolality of the cultures [251 and 258 mmol/kg for the vehicle control and the highest treatment concentration (3900 µg/ml), respectively]. Relative suspension growth (RSG) was 80, 51 and 10% at concentrations of 3900 µg/ml (4-hour treatments with and without S9) and 60.9 µg/ml (24-hour treatment without S9), respectively. RSG was or approximated 0% at concentrations ≥122 µg/ml (24-hour treatment without S9). COMPARISON WITH HISTORICAL CONTROL DATA: all positive and vehicle control values were within acceptable ranges, and all criteria for a valid study were met. ADDITIONAL INFORMATION ON CYTOTOXICITY:- Cultures treated at concentrations of 488, 975, 1950, 2930 and 3900 µg/mL (4-hour treatments with and without S9), and 30.5, 60.9, 91.4 and 122 µg/mL (24-hour treatment without S9) exhibited 78 to 115%, 22 to 92%, and 23 to 99% RSG, respectively.- Cultures treated at concentrations of 224 µg/ml (24-hour treatment without S9) were discarded prior to cloning due to excessive toxicity.- Cultures treated at concentrations 182 µg/ml (24-hour treatment without S9) were excluded from evaluation due to excessive toxicity.
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Mutagenesis assay:
- Cultures treated at concentrations of 488, 975, 1950, 2930 and 3900 µg/ml (4-hour treatments with and without S9), and 30.5, 60.9, 91.4 and 122 µg/ml (24-hour treatment without S9) exhibited 78 to 115%, 22 to 92%, and 23 to 99% RSG, respectively, and were cloned (cultures at a concentration of 488 µg/ml with S9 were lost due to technical error; cultures treated at other lower concentrations were discarded prior to cloning because a sufficient number of higher concentrations was available; cultures treated at other higher concentrations were discarded prior to cloning, or excluded from evaluation of mutagenicity, due to excessive toxicity). Relative total growth of the remaining cloned cultures ranged from 73 to 110% (4-hour treatment with S9), 20 to 97% (4-hour treatment without S9) and 13 to 86% (24-hour treatment without S9). No increases in average induced mutant frequency ≥90 mutants per 10E06 clonable cells were observed under any treatment condition.
- The trifluorothymidine-resistant colonies for the positive and solvent control cultures in the presence and absence of S9 were sized according to diameter, over a range from approximately 0.2 to 1.1 mm. The colony sizing for the MMS and DMBA positive controls yielded the expected increase in small colonies (verifying the adequacy of the methods used to detect small colony mutants) and large colonies.
Applicant's summary and conclusion
- Conclusions:
- The results indicate that the substance was negative in the L5178Y/TK+/- Mouse Lymphoma Assay under the conditions, and according to the criteria, of the test protocol.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Although ECHA is providing a lot of online material in your language, part of this page is only in English. More about ECHA’s multilingual practice.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
the-echa-website-uses-cookies
find-out-more-on how-we-use-cookies